Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-05-14
1997-05-06
Rories, Charles C. P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 536 245, A61K 4800, C07H 2104, C07H 2102, C12Q 168
Patent
active
056271581
ABSTRACT:
Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP-dependent protein kinases are disclosed along with pharmaceutical compositions containing these oligonucleotides as the active ingredients. These antisense oligonucleotides are useful for inhibiting the growth of cancer.
REFERENCES:
patent: 5087617 (1992-02-01), Smith
patent: 5097026 (1992-03-01), Jahnsen
patent: 5098890 (1992-03-01), Gewirtz et al.
Tortora, G. and Cho-Chung, Y.S., Type II Regulatory Subunit of Protein Kinase Restores cAMP-dependent Transcription in a cAMP-unresponsive Cell Line, J. Biol. Chem. 265(30):18067-18070 (Oct. 25, 1990).
Tortora, G. et al., Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells, Proc. Natl. Acad. Sci. USA 86:2849-2852 (Apr. 1989).
Tortora, G. et al., A RI.alpha. subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase inhibits proliferation of human HL-60 promyelocytic leukemia, Proc. Am. Assoc. Canc. Res. Annu. Meet. 31:38 (1990), Abstract No. 220.
Tortora, G. et al., Site-Selective cAMP Analogs at Micromolar Concentrations Induce Growth Arrest and Differentiation of Acute Promyelocytic, Chronic Myelocytic, and Acute Lymphocytic Human Leukemia Cell Lines, Blood 71(1):230-233 (Jan. 1988).
Taylor, S.S., et al., cAMP-dependent protein kinase: prototype for a family of enzymes, FASEB J. 2:2677-2685 (1988).
Tortora, G. et al., An antisense oligodeoxynucleotide targeted against the type II.sub..beta. regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects, Proc. Natl. Acad. Sci. USA 87:705-708 (Jan. 1990).
Tortora, G., et al., Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA 88:2011-2015 (Mar. 1991).
Stein, C.A. and Cohen, J.S., Phosphorothioate Oligodeoxynucleotide Analogues, in Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression, Cohen, ed., pp. 97-117, Boca Raton, Florida, CRC Press, Inc. (1989).
Sugden, P.H., and Corbin, J.D., Adenosine 3':5'-Cyclic Monophosphate-Binding Proteins in Bovine and Rat Tissues, Biochem. J. 159:423-437 (1976).
Tagliaferri, P. et al., Reverse Transformation of Harvey Murine Sarcoma Virus-transformed NIH/3T3 Cells by Site-selective Cyclic AMP Analogs, J. Biol. Chem. 263(1):409-416 (Jan. 5, 1988).
Schwartz, D.A. and Rubin, C.S., Identification and Differential Expression of Two Forms of Regulatory Subunits (RII) of cAMP-dependent Protein Kinases II in Friend Erythroleukemic Cells, J. Biol. Chem. 260(10):6296-6303 (May 25, 1985).
Scott, J.D. et al., The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain, Proc. Natl. Acad. Sci. USA 84:5192-5196 (Aug. 1987).
Stein, C.A. and Cohen, J.S., Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review, Canc. Res. 48:2659-2668 (May 15, 1988).
Potera, C., `Reverse Transformation` Studies Provide Clues for Treating Malignancies, Genetic Engineering News 5(8):20 (Sep. 1985).
Robinson-Steiner, A.M. and Corbin, J.D., Probable Involvement of Both Intrachain cAMP Binding Sites in Activation of Protein Kinase, J. Biol. Chem. 258(2):1032-1040 (Jan. 25, 1983).
Sandberg, M. et al., Molecular Cloning, cDNA Structure and Deduced Amino Acid Sequence for a Type I Regulatory Subunit of cAMP-Dependent Protein Kinase from Human Testis, Biochem. Biophys. Res. Comm. 149(3):939-945 (Dec. 31, 1987).
.O slashed.greid, D. et al., Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination: Principles for optimizing the isozyme specificity of analog combinations, Eur. J. Biochem. 150:219-227 (1985).
.O slashed.yen, O. et al., Human testis cDNA for the regulatory subunit RII.sub..alpha. of cAMP-dependent protein kinase encodes an alternate amino-terminal region, FEBS Letts. 246(1,2):57-64 (Mar. 1989).
Paterson, B.M. et al., Structural gene identification and mapping by DNA.cndot.mRNA hybrid-arrested cell-free translation, Proc. Natl. Acad. Sci. USA 74(10):4370-4374 (Oct. 1977).
Lee, D.C. et al., Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA 80:3608-3612 (Jun. 1983).
Levy, F.O., et al., Molecular Cloning, Complementary Deoxyribonucleic Acid Structure and Predicted Full-Length Amino Acid Sequence of the Hormone-Inducible Regulatory Subunit of 3'-5'-Cyclic . . . , Mol. Endo. 2(12):1364-1373 (1988).
Mizuno, T. et al., A unique mechanism regulating gene expression: Translational inhibition by a complementary RNA transcript (micRNA), Proc. Natl. Acad. Sci. USA 81:1966-1970 (Apr. 1984).
Iyer, R.P. et al., 3H-1,2-Benzodithiole-3-one 1,1-Dioxide as an Improved Sulfurizing Reagent in the Solid-Phase Synthesis of Oligodeoxyribonucleoside Phosphorothioates, J. Am. Chem. Soc. 112:1253-1254 (1990).
Jahnsen, T., et al., Molecular Cloning, cDNA Structure, and Regulation of the Regulatory Subunit of Type II cAMP-dependent Protein Kinase from Rat Ovarian Granulosa Cells, J. Biol. Chem. 261(26):12352-12361 (Sep. 15, 1986).
Katsaros, D. et al., Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth, FEBS Letts. 233(1):97-103 (Oct. 1987).
Corbin, J.D. et al., The Distribution and Dissociation of Cyclic Adenosine 3':5'-Monophosphate-dependent Protein Kinases in Adipose, Cardiac, and Other Tissues, J. Biol. Chem. 250(1):218-225 (Jan. 10, 1975).
Heywood, S.M., tcRNA as a naturally occurring antisense RNA in eukaryotes, Nucl. Acids Res. 14(16):6771-6772 (1986).
Hofmann, F. et al., Concentrations of Cyclic AMP-dependent Protein Kinase Subunits in Various Tissues, J. Biol. Chem. 252(4):1441-1447 (Feb. 25, 1977).
Clegg, C.H. et al., Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA 85:3703-3707 (Jun. 1988).
Cohen, J.S., Designing antisense oligonucleotides as pharmaceutical agents, Trends Pharamcol. Sci. 10(11):435-437 (1989).
Cohen, J.S., Topics in Molecular and Structural Biology, Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression, Natl. Cancer Inst., Bethesda, Md. pp. 1-6, Boca Roton, Florida, CRC Press, Inc. (1989).
Cho-Chung, Y., et al., An antisense oligodeoxynucleotide targeted against the type I regulatory subunit (RI.sub..alpha.) mRNA of cAMP-dependent protein kinase (PKA) inhibits the growth of LS-174T human colon carcinoma in athymic mice, Proc. Am. Assoc. Canc. Res. Annu. Meet. 32:277 (1991), Abstract No. 1645.
Cho-Chung, Y.S. et al., A RI.alpha. subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase blocks proliferation in human and rodent cancer cell lines by-passing exogenous cAMP effect, Proc. Am. Assoc. Canc. Res. Annu. Meet. 31:29 (1990) Abstract No. 171.
Cho-Chung, Y.S. et al., Site-Selective Cyclic AMP analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation, Canc. Invest. 7(2):161-177 (1989).
Ally, S., Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3'5',-cyclic monophosphate provides a biological means for control of human colon cancer cell growth, Proc. Natl. Acad. Sci. USA 85:6319-6322 (Sep. 1988).
Campbell, J.M. et al., Oligodeoxynucleoside Phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid, J. Biochem. Biophys. Meth. 20:259-267 (1990).
Cho-Chung, Y.S., Site-Selective 8-Chloro-Cyclic Adenosine 3',5'-Monophosphate as a Biologic Modulator of Cancer: Restoration of Normal Control Mechanisms, J. Natl. Canc. Inst. 81(13):982-987 (Jul. 5, 1989).
C. Stein et al., Science, vol. 261 (20 Aug. '93) pp. 1004-1012.
B. Tseng et al., Cancer Gene Therapy, vol. 1, No. 1 (Mar. 94) pp. 65-71.
R. Weiss, Science News, vol. 139 (16 Feb. '91) pp. 108-109.
R. Phillips et al., J.N.C.I., vol. 82, No. 18(19 Sep. '90) pp. 1457-1468.
K. Smith, et al. Eur
LandOfFree
Antisense oligonucleotides of human regulatory subunit RI-.sub.. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides of human regulatory subunit RI-.sub.., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides of human regulatory subunit RI-.sub.. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2132695